CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

Pharma’s $500B patent problem will come in waves — not as a cliff

Patent ExpiryNegative
AI Analysis

Summary

Pharma industry faces approximately $500B in patent expirations occurring gradually over time rather than as a sudden cliff, with Merck most vulnerable in the near term, followed by AbbVie, Johnson & Johnson, and Sanofi.

Importance:5/10
Sentiment:
-0.60
patent_expirygeneric_competitionpipeline_risk
Related Companies

Read the original article

Published by BioPharma Dive on October 12, 2026 1:16 PM

Read Original